Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Karuna Therapeutics Inc (KRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2020	12-2019	09-2019	06-2019	03-2019
Assets
Current Assets
Cash & Cash Equivalents	190,645	208,929	54,144	10,495	N/A
Marketable Securities	192,846	180,468	107,461	64,804	N/A
Other current assets	0	0	0	2,032	0
TOTAL	$386,668	$392,706	$163,928	$79,048	$N/A

Non-Current Assets
PPE Net	371	195	176	186	N/A
Other Non-Current Assets	2,679	123	123	123	0
TOTAL	$3,050	$318	$299	$309	$N/A

Total Assets	$389,718	$393,024	$164,227	$79,357	$N/A

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	603	547	158	960	0
Accrued Expenses	1,425	2,353	1,319	1,260	N/A
Other current liabilities	N/A	58	56	55	N/A
TOTAL	$2,652	$2,958	$1,533	$2,275	$N/A

Non-Current Liabilities
Other Non-Current Liabilities	2,125	150	164	124,071	0
TOTAL	$2,125	$150	$164	$124,071	$N/A

Total Liabilities	$4,777	$3,108	$1,697	$126,346	$N/A

Shareholders' Equity
Shares Outstanding, K	26,130	26,083	23,413	23,413	N/A
Common Shares	3	3	2	N/A	N/A
Retained earnings	-84,170	-75,512	-67,738	-58,700	N/A
Other shareholders' equity	1,571	5	50	71	0
TOTAL	$384,941	$389,916	$162,530	$-46,989	$N/A

Total Liabilities And Equity	$389,718	$393,024	$164,227	$79,357	$0